Clinical Trial: Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
Study Status: Completed
Recruit Status: RECRUITING
Condition: Actinic Keratosis
Study Type: INTERVENTIONAL
Official Title: Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
Brief Summary:
Interventional, monocentric, national, single-arm, uncontrolled, open, prospective phase IV study.Since this study is not powered for confirmative testing, analysis is done by descriptive statistics Eligible AK patients receive Tirbanibulin on sun-damaged areas of the face for five days, according to the SmPC.Diagnosis and monitoring of treatment effects are supported by UV imaging using Canfield VISIA®.Safety and efficacy are assessed at end of treatment visit (EoT, approximately 3 days after the last dose, i.e,…
Read more